Thymus-derived(T) lymphocytes have been shown to display antigen specificity. The antigen-recognition units on T lymphocytes, in contrast to those on B lymphocytes, do not appear to be of the conventional immunoglobulin (Ig) type. Recent studies from various laboratories (1-5) have demonstrated that the antigen-specific T cell factors derived from helper or suppressor T cells possess the antigen-binding moiety and the products of genes in the I region of the H-2 complex, whereas no Ig constant determinant has been defined. Antibodies against the variable (V) region of the Ig heavy chain (Igh) a or against idiotypes on the antibodies, however, have been shown to react with isolated T cell receptors for antigens as well as with antigenspecific helper and suppressor T cell factors (6-12). It is therefore suggested that the antigen-binding structure on T cell antigen-recognition units shares the V region markers with the conventional Ig on B cells. In this sense, the antigen-recognition units on T cells appear to possess a constant portion, as do Ig. However, the constant region determinants on T cell receptors or on antigen-specific T cell factors have so far not been defined.
of idiotype-specific suppressor T cells to the idiotype-bearing immunoglobulins. Therefore, products recognized by the antisera seem to be the conserved determinants on, or adjacent to, the antigen-binding site oft cell receptors. No direct evidence has, however, demonstrated that the conserved allotypic determinants are in fact on the antigen-recognition units of T ceils.
In this communication, we report that the alloantiserum produced by lgh allotype congenic pairs defines the conserved allotypic determinants on the small population of T cells that belong to Thy-1 dull-stained Lyt-2-or Lyt-2 + T cells of mice expressing lgh-lb allotype. The allotypic determinants recognized by the antiserum are expressed on the antigen-binding moiety of the functionally different T cell factors (i.e., antigenspecific helper and suppressor T cell factors). Both of the determinants are considered to be encoded by genes located in the right side of the lgh-V locus on the 12th chromosome. Furthermore, the product on the antigen-specific suppressor T cell factor defined by the antiserum is distinct from that on the antigen-specific helper (augmenting) T cell factor. 
Materials and Methods

Animals. BALB/c CrSlc (H-2 a, Igh-la), C57BL/6 CrSlc (H-2 b, lgh-lb), and C3H/HeSlc
Antigens. Keyhole limpet hemocyanin (KLH) was purchased from Calbiochem-Behring
Corp., American Hoechst Corp., San Diego, Calif. Dinitrophenylated KLH (DNP770-KLH) was prepared by coupling with 2,4-dinitrobenzenesulfonic acid under an alkaline condition.
BordeteUa pertussis vaccine (BPV) was purchased from the Chiba Serum Institute, Chiba, Japan. Antisera. The BALB/c anti-CB-20 alloantiserum was prepared by hyperimmunization of BALB/c mouse intravenously with 1 × 107 of CB-20 spleen cells precultivated with 5 #g/ml of concanavalin A (Con A; Sigma Chemical Co., St. Louis, Mo.) for 48 h at 37°C in a 5% CO2 incubator. The Con A-stimulated CB-20 spleen cells were treated with 100 #g/ml of mitomycin C (Kyowa Hakko Kogyo Co. Ltd., Tokyo, Japan) for 45 min at 37°C before immunization. The animals were immunized weekly, and beginning at the 1 lth wk, they were partially bled from a tail vein immediately before each immunization. The serum bled from each animal every week was pooled to make one lot and stored at -80°C before use. Only lot 2 of the antiserum was used in the studies. Monoclonal mouse IgM anti-Thy-l.2 (F7D5) was kindly provided by Dr. P. Lake, Georgetown University, Wash., D. C. Monoclonal rat antibodies against Lyt-1 (53-7.3), Lyt-2 (53-6.7), Thy-l.2 (30-H-12), and affinity-purified mouse (SJL) anti-rat Ig were gifts from Dr. J. A. Ledbetter, Department of Genetics, Stanford University, Stanford, Calif.
Cytotoxic Test. The two-step cytotoxic assay was performed. 10 #1 of 1 × 107/ml lymphoid cells from different tissues suspended in RPMI 1640 medium containing 1% fetal calf serum (FCS) and t9.1% NaN3 was incubated with 10 #1 of diluted antiserum for 30 rain at 4°C. After one washing the cells were treated with 20 #1 of a 1:8 diluted rabbit complement (C) for 30 min at 37°C. Live and dead cells were counted under a light microscope by the trypan blue dye exclusion method. Percent cytotoxicity was calculated by the following formula:
percent dead experimental -percent dead C control percent cytotoxicity ffi × i00. 100% -percent dead C control 200 cells were counted per well in the dye exclusion cytotoxic assay.
Quantitative Absorption of BALB/c Anti-CB-20 Antiserum with Cells.
Quantitative absorption studies were carried out in a V-bottomed microtiter plate (Dynatech Laboratories, Inc., Dynatech Corp., Alexandria, Va.). 30 #l of the 1:10 diluted antiserum that showed the end point of maximum cytotoxicity was absorbed with graded numbers of lymphoid cells from various strains of mice for 1 h at 4°C. The supernatants were collected by centrifugation and then tested for their eytotoxic activities on C57BL/6 thymocytes.
Cytotoxic Treatment of Spleen Cells with a Monoclonal Anti-Thy-l.2.
10 million/ml C57BL/6 spleen cells were reacted with 10/zg of monoclonal mouse anti-Thy-l.2 (F7D5) antibodies for 30 rain at room temperature. The cells were washed once and incubated with 1:10 diluted guinea pig C for 45 min at 37°C. The cells were again treated with anti-Thy-l.2 and C and then fractionated by Ficoll-Conley (Pharmacia Fine Chemicals, Uppsala, Sweden) to remove dead cells. Cell Surface Staining. 1 million lymphocytes in 100/.tl RPMI 1640 medium containing 1% FCS and 0.1% NaN3 were reacted with 1 btg of monoclonal rat antibody (anti-Lyt-1, anti-Lyt-2, or anti-Thy-1.2) for 30 min at 4°C. Cells were washed twice and then stained with fluoresceinconjugated mouse anti-rat Ig reagents for 30 rain at 4°C. Stained cells were analyzed by a fluorescence-activated cell sorter (FACS-IV; B-D FACS Systems, Becton, Dickinson & Co., Sunnyvale, Calif.).
Purification of T Cells from
Preparation of the KLH-specific Suppressor T Cell Factor (TsF) and the KLH-specific Augmenting T Cell Factor (TaF).
The methods for obtaining KLH-specific TsF and TaF have been described in detail elsewhere (1, 2) . In brief, mice were immunized intraperitoneally twice with 200 #g of KLH at 2-wk intervals. 2 wk after the last immunization, thymocytes or spleen cells from C57BL/6 or BALB/c mice were obtained and subsequently disrupted by freezing and thawing. The cell-free extracts were obtained by uhracentrifugation at 40,000 g for 1 h. Monoclonal KLH-TsF was extracted by the same method as above (17) from suppressor T cell hybridoma (34S-704) made by a fusion of AKR thymoma cells (BW5147) and KLH-specific suppressor T cells from C57BL/6 mice.
Absorption and Elution of KLH-TsF and KLH-TaF with Immunoadsorbent
Columns. 10 mg KLH or 1 ml gamma globulin fraction of antisera was coupled with 1 ml of Sepharose 4B (Pharmacia Fine Chemicals) by the method of Ax~n et al. (18) . They were packed in a 1-ml disposable plastic syringe. The KLH-TsF or KLH-TaF was applied to the immunoadsorbent columns and incubated for 1 h at 4°C. Effluent was collected by passing through the columns. After extensive washing with RPMI 1640 medium, the active materials were eluted from the columns with 2 ml of 0.175 M glycine HC1 buffer, pH 3.2, at 4°C. The eluted materials were instantly neutralized with 1 M sodium bicarbonate and dialyzed with phosphate-buffered saline. They were then concentrated by vacuum pressure. Both effluent and eluate were tested for activity in the in vitro secondary antibody response as described below.
In some experiments, monoclonal KLH-TsF extracted from 1 × 109 hybridoma cells (34S-704) was absorbed with the BALB/c anti-CB-20 column to cover the reactive sites of antibodies specific for TsF. After washing the column with 20 ml chilled medium (RPMI 1640), it was incubated with medium for 1 h at 0°C. Effluent from the column was then added to the culture of DNP-KLH spleen cells on day 0 or day 2, and then tested for activity to confirm whether monoclonal KLH-TsF was discharged from the column during the incubation. Spleen cell extract from KLH-primed C57BL/6 mice equivalent to 1 × 10 7 cells was subsequently absorbed with the monoclonal KLH-TsF preabsorbed column of the anti-CB-20. Activity of KLH-TsF or KLH-TaF in the effluent or the eluate from the column was tested in the in vitro antibody response by addition of the. materials to the culture on day 0 or day 2.
In Vitro Culture System. 4 million spleen cells from C57BL/6 or BALB/c mice primed 6 wk previously with 100 #g of DNP-KLH and 109 BPV were cultured in the Mishell-Dutton system in the presence of 0.1 #g/ml of DNP-KLH at 37°C in 5% CO2 in air for 5 d. For assaying the TsF or the TaF activity, the cell-free extract from 1 X 10 7 KLH-primed spleen or thymus cells, or 5 × 105 hybridoma cells were added to the culture on day 0 or day 2, respectively. 5 d later, the numbers of anti-DNP IgG plaque-forming cells (PFC) were assayed by using DNP-coupled erythrocytes.
Statistical Analysis. For in vitro assays, results were analyzed with a two-tailed Student's t test. Probability values of > 10% were considered to be insignificant. 
Results
T Cell Reactivity
Genetic Specificity of BALB/c Anti-CB-20 Antiserum.
To demonstrate the genetic specificity of the BALB/c anti-CB-20 antiserum, the reactivity was investigated by the dye exclusion cytotoxic assay on thymocytes derived from various strains of mice including allotype congenic mice: (19) .
Tissue Distribution of Cells Sensitive to BALB/c Anti-CB-20.
To study the tissue distribution of ceils sensitive to the antiserum, spleen, thymus, and lymph node cells from C57BL/6 mice were tested by a dye exclusion cytotoxic assay. The results shown in Fig. 3 demonstrate that the 1:10 diluted antiserum killed ~20% of the thymocytes (Thy-1 + >95%) or the lymph node cells (Thy-1 + 40%), and 5% of the spleen cells (Thy-1 + 30%). When spleen cells purified with the nylon wool column (splenic T, Thy-1 + 75%, Ig + <1%) were treated with the 1:I0 diluted antiserum and C, 25% were sensitive to the antiserum. These results indicate that some but not all peripheral T cells are also sensitive to the antiserum. The absorbed materials were also eluted from the columns with glycine-HC1 buffer. Both effluent and eluate were added to the in vitro secondary response of DNP-KLHprimed C57BL/6 or BALB/c spleen cells on day 0 and tested for their suppressor activities. As shown in Table I , the suppressor activity of the KLH-TsF from C57BL/6 mice was absorbed to and eluted from the column of the anti-CB-20 antiserum, whereas the BALB/c derived KLH-TsF did not react to the same column.
Subsets of T Cells Sensitive to BALB/c Anti-CB-20. Subpopulations of splenic T cells
Furthermore, the factors from C57BL/6 and BALB/c mice were antigen specific, since the activities were absorbed to and eluted from the KLH column. The results Igh-1 b) * The anti-CB-20 column, which had been absorbed with a large quantity of the monoclonal KLH-TsF, was extensively washed and was further incubated with medium (RPMI 1640) for I h at 0°C. The effluent from the column was then added to the culture on day 0 or day 2, and was tested for the activity to confirm whether the active materials were discharged from the column. Spleen cell extract from KLHprimed 057BL/6 mice equivalent to 1 x l0 T cells was subsequently absorbed with the monoclonal TsF-preabsorbed anti-CB-20 column. The effluent or the eluate from the column was added to the culture of DNP-KLH-primed C57BL/6 spleen cells on day 0 or day 2 in order to test suppressor or enhancing activity. :~ Arithmetic means and standard deviations of four cultures.
TAnLE II
Successful Absorption of the KLH-TaF from C57BL/6 (
Presence of Two Distinct Antibodies in BALB/c Anti-CB-20, Each of Which Defines the KLH-TsF or the KLH-TaF
§ Monoclonal KLH-TsF from the T cell hybridoma (34S-704) equivalent to 5 X l0 b cells was absorbed to the anti-CB-20 column. The absorbed materials were eluted from the column with acid. The eluate or the effluent was tested for its suppressor activity in the in vitro secondary response of DNP-KLH-primed C57BL/6 spleen cells.
Jl Not done. ¶ Monoclonal KLH-TsF in hybridoma extract equivalent to 1 x 109 cells was applied to the anti-CB-20 column to cover the binding site of antibodies specific for TsF. strongly suggest that the antiserum reacts to the allotypic determinants on the antigenspecific suppressor T cell factor.
Absorption of KLH-TaF with the Column of BALB/c Anti-CB-20. It is known that the soluble extract obtained from KLH-primed spleen cells or thymocytes augments
antibody responses in an antigen-specific fashion when the factor was added to culture on day 2 (2). Furthermore, antigen-specific TaF was also found to bear the antigen-binding moiety and the products encoded by genes in the I-A subregion of the H-2 complex (2). As a result, experiments were carried out to establish whether the KLHTaF could have determinants detected by the BALB/c anti-CB-20. The KLH-TaF from primed spleen cells of C57BL/6 or BALB/c mice was absorbed with the immunoadsorbent columns of KLH or the antiserum. Augmenting activities in the effluent or the eluate from the columns were tested by addition of the materials to the in vitro secondary culture on day 2. Table II shows results demonstrating that KLH-TaF from both C57BL/6 and BALB/c mice were absorbed to and eluted from the KLH column. The column composed of the anti-CB-20 antiserum, however, absorbed KLH-TaF from C57BL/6 but not from BALB/c mice. These results indicate that the anti-CB-20 antiserum also detects allotypic determinants on the antigenspecific TaF.
BALB/c Anti-CB-20 Defines Two Distinct Allotypic Determinants on the Antigen-recognition Units on T Cells, Each of Which Is Expressed on the KLH-TaF or the KLH-TsF.
In our previous experiments, monoclonal KLH-TsF derived from T cell hybridoma (34S-704) made by the fusion of a thymoma cell line, BW5147, and C57BL/6 (Igh-1 b) KLH-specific suppressor T cells, was shown to have the same immunochemical and physicochemical properties as that of conventional KLH-TsF (17, 20) . In fact, the results shown in the upper part of Table III demonstrate that the monoclonal KLHTsF, like the C57BL/6-derived KLH-TsF, carried the determinants recognized by the anti-CB-20 antiserum, because activity of the monoclonal KLH-TsF was absorbed to and eluted from the anti-CB-20 column.
Based on these results, experiments were carried out to investigate whether the determinants on the KLH-TsF detected by the anti-CB-20 antiserum are distinct from those on the KLH-TaF. The anti-CB-20 column was incubated with monoclonal KLH-TsF in extracted materials equivalent to 1 × 109 hybridoma cells at 0°C for 1 h, and then extensively washed with the medium. 500/11 RPMI 1640 was further incubated with the column at 0°C for 1 h. The effluent from the column was added to the culture on day 0 or day 2 to test whether the active materials were discharged from the column during the 1-h incubation. As shown in Table III , the effluent from the anti-CB-20 column absorbed with a large amount of the monoclonal KLH-TsF had no detectable suppressor and enhancing activities, indicating that active materials were not discharged from the column during incubation with medium. Therefore, KLH-primed spleen cell extract of C57BL/6 mice equivalent to 1 × 107 cells was subsequently absorbed with the anti-CB-20 column preabsorbed with a large amount of monoclonal KLH-TsF. Suppressor or enhancing activity in the effluent or the eluate from the column was tested in the in vitro secondary response by addition of materials to culture on day 0 or day 2. As shown in the lower part of Table III , enhancing activity was absorbed to and eluted from the column, whereas there was no longer any suppressor activity absorbed. These results indicate that the monoclonal KLH-TsF preabsorbed column preserves the capacity to absorb KLH-TaF but not KLH-TsF.
Discussion
It is known that two distinct types of T cell factors, with different functions, are found in materials extracted from spleen or thymus cells of mice hyperimmunized with KLH (1, 2). These factors, KLH-TsF and -TaF, can suppress or enhance the antihapten IgG PFC responses to DNP-KLH (1, 2, 21) . Furthermore, we have clearly shown that both KLH-TsF and KLH-TaF bear the antigen-binding moiety and the products coded for by genes in the I subregion of the H-2 complex (1, 2) . Subregion specifieities of the I region products on the KLH-specifie TsF and TaF were serologically determined to be the I-J and I-A subregion of the H-2 complex, respectively (2, 21) .
Immunochemical analyses of KLH-TsF derived from T cell hybridomas have also shown that the suppressor factor is composed of two distinct polypeptide chains, i.e., the antigen-binding and the/-J-encoded chains in covalent or noncovalent association, whereas no Ig constant region determinant has been demonstrated (1, 17, 20, 22) . Recent reports from various laboratories (6-12) have, however, indicated that the antigen-specific helper and suppressor factors carry a structure analogous or identical to the V region of Igh. As a result, it is conceivable that at least two genes are involved in coding for the structural entity of antigen-specific T cell factors: one located in the (Figs. 3 and 4) . The reactivity of the antiserum to the T cell population was confirmed by the quantitative absorption analysis with lymphoid cells. As shown in Fig. 1 , the antibody activity was completely absorbed with thymus and spleen cells, whereas spleen cells treated twice with anti-Thy-1 and C (Thy-1 negative population) did not absorb the reactivity to thymocytes at all. The results indicate that BALB/c anti-CB-20 antiserum definitely contains antibodies against the alloantigenic determinant on T cells but not on B cells. The products detected by antiserum were found to be expressed on splenic T cells far more than on thymocytes, because 2 × 10 e spleen cells containing 30% T cells (in which only 5% were sensitive to the antiserum) (Fig. 3) had the same capacity to absorb activity as 2 × 106 thymocytes (Fig. 1) . Moreover, the antiserum selectively killed the Thy-1 dull-stained population in splenic T cells (Fig. 5 ). In general, T cells lose Thy-1 antigens on their surface with the progression of maturation (23) . Thus, mature T cells are more sensitive to the antiserum than thymocytes. This is in agreement with the data reported by Owen et al. (13) .
The genetic specificity of the anti-CB-20 antiserum was determined in two ways. First, the antibody activity was tested by the dye exclusion cytotoxic assay on thymocytes from various strains of mice with different Igh allotypes. Second, quantitative absorption studies with thymocytes from various Igh allotype mice were carried out. The absorbed antiserum was then tested for cytotoxic activity on thymocytes of (14) . From these results, they have postulated that the Tsu a antigen is associated with the T cell receptor. However, they have not formally demonstrated direct evidence that the anti-Ysu a antiserum recognizes the determinants on the T cell receptor.
Igh
Our results, illustrated in Tables I and II, A striking difference between Owen's (13-15) and our antisera is that our anti-CB-20 antiserum contains at least two distinct antibodies with different specificities: the one specific for antigen-specific TsF, and the other for the antigen specific TaF. Owen's antiserum reacts only to the Lyt-2 + suppressor T cells. As shown in Table III , the immunoadsorbent column of the anti-CB-20 preabsorbed with a large quantity of monoclonal KLH-TsF could preserve the absorbing capacity of KLH-TaF from Igh-1 b mice, while conventional KLH-TsF was no longer absorbed with the same column. These results were supported by the evidence that T cells sensitive to anti-CB-20 belonged to both Lyt-2-and Lyt-2 ÷ populations (Fig. 4) , each of which produces antigen-specific TaF and TsF. Consequently, it is apparent that antigen-specific TaF and TsF carry the distinct allotypic determinants on the antigen-recognition units, both of which are encoded by genes located in the right side of Igh-V genes.
The allotypic determinants detected by the anti-CB-20 antiserum seem to be commonly shared within each functional activity of the respective T cell factors, as preabsorption of the anti-CB-20 column with the monoclonal KLH-TsF completely eliminated antibody activity against the conventional KLH-TsF (Table III) . As the antiserum was produced by immunizations with unprimed Con A-stimulated CB-20 spleen cells, it should not contain antibodies against idiotype-like determinants on the T cell antigen-receptors. Thus, it is conceivable that allotypic markers defined by antiserum represent determinants on the antigen-binding molecules of antigen-specific T cell factors outside of the antigen-binding site (i.e., constant region determinants). If so, every T cell factor with a particular function may express a structurally related determinant like the Igh-C allotype. In this sense, it is reasonable to consider that the cluster of genes coding for different allotypic markers on the constant region of functional T cell factors or receptors is located somewhere around the Igh-genes on the 12th chromosome. (Igh-V) cluster, as the antibody activity was completely absorbed with BAB-14 thymocytes. It was also demonstrated that the products detected by the antiserum represent the allotypic determinants (probably constant region determinants) on the antigen-binding moiety of the antigen-specific augmenting (TaF) and suppressor (TsF) T cell factors. Moreover, determinants on TsF were found to be distinct from those on TaF. Therefore, it can be suggested that the two genes coding for the T cell allodeterminants (distinct from those of the B cell Igh) are located in the right side of the B cell Igh-V on the 12th chromosome, and that both encode the antigen-recognition units of the functionally distinct T cell factors.
We thank Dr. K. Okumura, University of Tokyo, Japan, for a generous supply of congenic and recombinant mice of various allotypes. We also wish to express our gratitude to Professor T. Tada, University of Tokyo, Japan, for his constructive criticism. Furthermore, we extend our sincerest appreciation to Dr. Y. Komatsu for his excellent technical assistance and to Miss Hisano Nakajima for her kind secretarial assistance.
Received for publication 8 September 1981. 
